A Pharmacokinetic Interaction Study of Sorafenib and Iced Teas in Rats Using UPLC-MS/MS: An Illustration of Beverage-Drug Interaction

Iced teas (ITs), also known as ready-to-drink teas, have gained much popularity among many nations. The modulatory effect of tea beverages on CYP3A4 increases the possibility of their potential interactions with many coadministered medications. Being a substrate of CYP3A4, sorafenib (SOR), the first...

Full description

Bibliographic Details
Main Authors: Hadir M. Maher, Aliyah Almomen, Nourah Z. Alzoman, Shereen M. Shehata, Amal Al-Subaie
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2019/2410845
id doaj-db83ee2835cd48138952a3617e20d492
record_format Article
spelling doaj-db83ee2835cd48138952a3617e20d4922020-11-25T01:58:18ZengHindawi LimitedBioMed Research International2314-61332314-61412019-01-01201910.1155/2019/24108452410845A Pharmacokinetic Interaction Study of Sorafenib and Iced Teas in Rats Using UPLC-MS/MS: An Illustration of Beverage-Drug InteractionHadir M. Maher0Aliyah Almomen1Nourah Z. Alzoman2Shereen M. Shehata3Amal Al-Subaie4College of Pharmacy, Department of Pharmaceutical Chemistry, King Saud University, Riyadh 11495, P.O. Box 22452, Saudi ArabiaCollege of Pharmacy, Department of Pharmaceutical Chemistry, King Saud University, Riyadh 11495, P.O. Box 22452, Saudi ArabiaCollege of Pharmacy, Department of Pharmaceutical Chemistry, King Saud University, Riyadh 11495, P.O. Box 22452, Saudi ArabiaCollege of Pharmacy, Department of Pharmaceutical Chemistry, King Saud University, Riyadh 11495, P.O. Box 22452, Saudi ArabiaSaudi Food and Drug Authority, Biologics and Evaluation Department, Riyadh, Saudi ArabiaIced teas (ITs), also known as ready-to-drink teas, have gained much popularity among many nations. The modulatory effect of tea beverages on CYP3A4 increases the possibility of their potential interactions with many coadministered medications. Being a substrate of CYP3A4, sorafenib (SOR), the first-line therapy for the treatment of hepatocellular carcinoma, shows a great probability to exhibit pharmacokinetic (PK) interaction with ITs. For this purpose, different groups of Wistar rats were given oral doses of SOR (40 mg/kg), along with different types of ITs. The concentration of SOR in rat plasma was determined using UPLC-MS/MS. Chromatographic analysis was performed on a C18 analytical column, Acquity UPLC BEH™ (100 × 1.0 mm, i.d., 1.7 μm particle size), using erlotinib (ERL) as an internal standard. Isocratic elution was performed with a mobile phase consisting of two solvents: solvent A (water with 0.1% formic acid) and solvent B (acetonitrile with 0.1% formic acid), in a ratio of 30 : 70, v/v, respectively. Quantitation was performed using MRM of the transitions from protonated precursor ions [M+H]+ to product ions at m/z 465.12 > 252.02 (SOR) and m/z 394.29 > 278.19 (ERL). The method was fully validated as per the FDA guidance for bioanalytical method validation in the concentration range of 2.5–500 ng/mL. Different PK parameters were calculated for SOR in all rat groups and groups administered with ITs and SOR, compared with groups with simply water and SOR. Experimental data revealed that ITs caused a general reduction in SOR bioavailability; an approximate reduction of 30% was recorded for all types of tested ITs. These data indicate that ITs could affect the PK profile of SOR in rats.http://dx.doi.org/10.1155/2019/2410845
collection DOAJ
language English
format Article
sources DOAJ
author Hadir M. Maher
Aliyah Almomen
Nourah Z. Alzoman
Shereen M. Shehata
Amal Al-Subaie
spellingShingle Hadir M. Maher
Aliyah Almomen
Nourah Z. Alzoman
Shereen M. Shehata
Amal Al-Subaie
A Pharmacokinetic Interaction Study of Sorafenib and Iced Teas in Rats Using UPLC-MS/MS: An Illustration of Beverage-Drug Interaction
BioMed Research International
author_facet Hadir M. Maher
Aliyah Almomen
Nourah Z. Alzoman
Shereen M. Shehata
Amal Al-Subaie
author_sort Hadir M. Maher
title A Pharmacokinetic Interaction Study of Sorafenib and Iced Teas in Rats Using UPLC-MS/MS: An Illustration of Beverage-Drug Interaction
title_short A Pharmacokinetic Interaction Study of Sorafenib and Iced Teas in Rats Using UPLC-MS/MS: An Illustration of Beverage-Drug Interaction
title_full A Pharmacokinetic Interaction Study of Sorafenib and Iced Teas in Rats Using UPLC-MS/MS: An Illustration of Beverage-Drug Interaction
title_fullStr A Pharmacokinetic Interaction Study of Sorafenib and Iced Teas in Rats Using UPLC-MS/MS: An Illustration of Beverage-Drug Interaction
title_full_unstemmed A Pharmacokinetic Interaction Study of Sorafenib and Iced Teas in Rats Using UPLC-MS/MS: An Illustration of Beverage-Drug Interaction
title_sort pharmacokinetic interaction study of sorafenib and iced teas in rats using uplc-ms/ms: an illustration of beverage-drug interaction
publisher Hindawi Limited
series BioMed Research International
issn 2314-6133
2314-6141
publishDate 2019-01-01
description Iced teas (ITs), also known as ready-to-drink teas, have gained much popularity among many nations. The modulatory effect of tea beverages on CYP3A4 increases the possibility of their potential interactions with many coadministered medications. Being a substrate of CYP3A4, sorafenib (SOR), the first-line therapy for the treatment of hepatocellular carcinoma, shows a great probability to exhibit pharmacokinetic (PK) interaction with ITs. For this purpose, different groups of Wistar rats were given oral doses of SOR (40 mg/kg), along with different types of ITs. The concentration of SOR in rat plasma was determined using UPLC-MS/MS. Chromatographic analysis was performed on a C18 analytical column, Acquity UPLC BEH™ (100 × 1.0 mm, i.d., 1.7 μm particle size), using erlotinib (ERL) as an internal standard. Isocratic elution was performed with a mobile phase consisting of two solvents: solvent A (water with 0.1% formic acid) and solvent B (acetonitrile with 0.1% formic acid), in a ratio of 30 : 70, v/v, respectively. Quantitation was performed using MRM of the transitions from protonated precursor ions [M+H]+ to product ions at m/z 465.12 > 252.02 (SOR) and m/z 394.29 > 278.19 (ERL). The method was fully validated as per the FDA guidance for bioanalytical method validation in the concentration range of 2.5–500 ng/mL. Different PK parameters were calculated for SOR in all rat groups and groups administered with ITs and SOR, compared with groups with simply water and SOR. Experimental data revealed that ITs caused a general reduction in SOR bioavailability; an approximate reduction of 30% was recorded for all types of tested ITs. These data indicate that ITs could affect the PK profile of SOR in rats.
url http://dx.doi.org/10.1155/2019/2410845
work_keys_str_mv AT hadirmmaher apharmacokineticinteractionstudyofsorafenibandicedteasinratsusinguplcmsmsanillustrationofbeveragedruginteraction
AT aliyahalmomen apharmacokineticinteractionstudyofsorafenibandicedteasinratsusinguplcmsmsanillustrationofbeveragedruginteraction
AT nourahzalzoman apharmacokineticinteractionstudyofsorafenibandicedteasinratsusinguplcmsmsanillustrationofbeveragedruginteraction
AT shereenmshehata apharmacokineticinteractionstudyofsorafenibandicedteasinratsusinguplcmsmsanillustrationofbeveragedruginteraction
AT amalalsubaie apharmacokineticinteractionstudyofsorafenibandicedteasinratsusinguplcmsmsanillustrationofbeveragedruginteraction
AT hadirmmaher pharmacokineticinteractionstudyofsorafenibandicedteasinratsusinguplcmsmsanillustrationofbeveragedruginteraction
AT aliyahalmomen pharmacokineticinteractionstudyofsorafenibandicedteasinratsusinguplcmsmsanillustrationofbeveragedruginteraction
AT nourahzalzoman pharmacokineticinteractionstudyofsorafenibandicedteasinratsusinguplcmsmsanillustrationofbeveragedruginteraction
AT shereenmshehata pharmacokineticinteractionstudyofsorafenibandicedteasinratsusinguplcmsmsanillustrationofbeveragedruginteraction
AT amalalsubaie pharmacokineticinteractionstudyofsorafenibandicedteasinratsusinguplcmsmsanillustrationofbeveragedruginteraction
_version_ 1724970381790412800